UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015980 |
|---|---|
| Receipt number | R000018581 |
| Scientific Title | A phase I study (investigator-initiated) on the safety and pharmacokinetics of Bortezomib with combination chemotherapy in pediatric and young adult patients with refractory acute lymphocytic leukemia |
| Date of disclosure of the study information | 2014/12/17 |
| Last modified on | 2017/07/25 09:50:59 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/12/17 17:46:04 | ||
| 2 | Update | 2014/12/17 17:51:02 | UMIN ID1 |
|
| 3 | Update | 2015/01/23 15:58:08 | Recruitment status |
|
| 4 | Update | 2015/04/06 11:47:09 | Last follow-up date |
|
| 5 | Update | 2015/06/22 11:50:44 | Organization Last name of contact person Last name of contact person Organization Organization |
|
| 6 | Update | 2015/06/23 09:31:28 | Organization |
|
| 7 | Update | 2015/08/28 14:57:12 | Institute Institute |
|
| 8 | Update | 2015/12/17 16:38:59 | Last follow-up date |
|
| 9 | Update | 2016/01/20 09:05:53 | Recruitment status |
|
| 10 | Update | 2016/04/22 15:53:11 | Date trial data considered complete Date analysis concluded |
|
| 11 | Update | 2017/07/25 09:50:59 | UMIN ID2 |
